Skip to content

IV Acetaminophen in Children Undergoing Palatoplasty

A Prospective, Double-Blinded, Randomized Comparison of Intravenous Acetaminophen Versus Placebo in Children Undergoing Palatoplasty

Status
Withdrawn
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01760330
Enrollment
0
Registered
2013-01-04
Start date
2015-12-31
Completion date
2016-12-31
Last updated
2016-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cleft Palate

Brief summary

This project is being used to assess the utility of intravenous acetaminophen in the pediatric population undergoing palate repairs. This study is a prospective randomized double blinded placebo controlled study. The investigators will have two arms, one group of patients will receive intravenous acetaminophen and one group that will receive a placebo at a total of four doses over 24 hours. The results of this study may affect the intraoperative anesthetic management as well as post-operative surgical management of this specific patient population. The goal is to determine the benefit of adding a non-opioid analgesic and hypothesizing that it may reduce the amount of narcotic consumption in the post anesthesia care unit as well as during the post-operative stay.

Interventions

DRUGIV acetaminophen
DRUGPlacebo

Sponsors

Nationwide Children's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* ASA physical status I or II * Presenting for repair of palatoplasty with Drs. Kirschner or Pearson

Exclusion criteria

* ASA physical status \> II * Underlying Syndrome * Significant co-morbid diseases (cardiac, pulmonary, neurological disease) * Patients having concomitant procedures (tonsillectomy, adenoidectomy, etc.)

Design outcomes

Primary

MeasureTime frameDescription
Pain24 hrs. post-op.Pain scores will be assessed.

Secondary

MeasureTime frame
Opioid consumption24 hrs. post-op

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026